将记忆支持干预整合到睡眠与昼夜节律功能障碍跨诊断干预(TranS-C)中:改善中年和老年人对治疗的记忆能否改善患者结局?一项随机对照试验的研究方案
本研究为确证性疗效试验,将178名中年和老年人随机分配至TranS-C联合记忆支持干预(MSI)组或单用TranS-C组,两组均接受8次每周50分钟的治疗,并在治疗前、治疗后、6个月和12个月随访时评估。研究旨在检验简化版MSI能否改善睡眠与昼夜节律功能、日间功能、幸福感及患者记忆,并探讨患者记忆的中介作用及亚组调节效应。
要点
- 纳入178名中年和老年人,随机分配至TranS-C联合MSI组或单用TranS-C组。
- 两组均接受8次每周50分钟的治疗,评估时间点为治疗前、治疗后、6个月和12个月随访。
- 主要目标为比较两组对睡眠与昼夜节律功能、日间功能、幸福感和患者记忆的影响。
核心结论
- 本研究有潜力为简化版MSI维持健康、幸福感和功能的疗效提供证据,为MSI在中年和老年人及睡眠与昼夜节律问题治疗中的更广泛应用提供证据,并为MSI对可能受益亚组的疗效提供证据。
研究设计与样本
- 确证性疗效随机对照试验,计划纳入178名中年和老年人,随机分配至TranS-C联合MSI组或单用TranS-C组,两组均接受8次每周50分钟的治疗。
主要发现
- 目标1将比较TranS-C联合MSI组与单用TranS-C组对睡眠与昼夜节律功能、日间功能、幸福感和患者记忆的影响。
- 目标2将检验患者对治疗的记忆是否中介治疗条件与患者结局之间的关系。
- 目标3将评估既往报告的疗效反应不佳亚组是否调节治疗条件与患者对治疗的记忆及治疗结局之间的关系。
- 探索性分析将比较治疗条件对患者依从性、患者评定的治疗可信度和患者对治疗内容利用的影响,以及对提供者评定的可接受性、适当性和可行性的影响。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Poor memory for treatment is associated with poorer treatment adherence and poorer patient outcomes. The memory support intervention (MSI) was developed to improve patient memory for treatment with the goal of improving patient outcomes. The aim of this study protocol is to conduct a confirmatory efficacy trial to test whether a new, streamlined, and potent version of the MSI improves outcomes for midlife and older adults. This streamlined MSI is comprised of constructive memory supports that will be applied to a broader range of treatment content. The platform for this study is the Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C). We will focus on midlife and older adults who are low income and experiencing mobility impairments. METHODS: Participants (N = 178) will be randomly allocated to TranS-C + MSI or TranS-C alone. Both intervention arms include eight 50-min weekly sessions. Assessments will be conducted at pre-treatment, post-treatment, 6-, and 12-month follow-up (6FU and 12FU). Aim 1 will compare the effects of TranS-C + MSI versus TranS-C alone on sleep and circadian functioning, daytime functioning, well-being, and patient memory. Aim 2 will test whether patient memory for treatment mediates the relationship between treatment condition and patient outcomes. Aim 3 will evaluate if previously reported poor treatment response subgroups will moderate the relationship between treatment condition and (a) patient memory for treatment and (b) treatment outcome. Exploratory analyses will compare treatment condition on (a) patient adherence, patient-rated treatment credibility, and patient utilization of treatment contents, and (b) provider-rated acceptability, appropriateness, and feasibility. DISCUSSION: This study has the potential to provide evidence for (a) the efficacy of a new simplified version of the MSI for maintaining health, well-being, and functioning, (b) the wider application of the MSI for midlife and older adults and to the treatment of sleep and circadian problems, and (c) the efficacy of the MSI for sub-groups who are likely to benefit from the intervention. TRIAL REGISTRATION: ClinicalTrials.gov NCT05986604. Registered on 2 August 2023.
引用
- Milner AE, Hache RE, Oliver S, et al. Integrating the Memory Support Intervention into the Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C): can improving memory for treatment in midlife and older adults improve patient outcomes? Study protocol for a randomized controlled trial. Trials. 2024. PMID: 39363383. doi:10.1186/s13063-024-08468-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。